Category Archives: Drugs for Diabetes

Drug Review: Insulin

Insulin is life-saving for type 1 diabetics.  Many type 2 diabetics will eventually, if not at the outset, need to take insulin for adequate control of blood sugars, which should help prevent diabetes complications.

My comments here are simply a brief review of insulins used by type 2 diabetics.  Anyone taking insulin must work closely with a physician or diabetes nurse educator on proper dosing, injection technique, and recognition and management of hypoglycemia (low blood sugar).

This is NOT an insulin rig! Modern insulin injections barely hurt, if at all.

Insulin’s Mechanism of Action
 

 

 

Insulin is made by the pancreas to keep blood sugars from rising above a fairly strict range: 70-140 mg/dl or 3.89-7.78 mmol/l.  [It has many other actions that I won’t bother to outline here.]  When we eat a meal containing carbohydrates (and proteins to a lesser extent), blood sugar starts to rise as we digest the carbs.  Insulin drives the sugar into our body’s cells for use as immediate energy or conversion to fat as stored energy.  About half of the insulin produced by a healthy body is “basal,” meaning it’s secreted into the bloodstream in a steady, low-volume amount, to keep the liver from making too much sugar (glucose) and controlling fasting sugar levels.  The other half is secreted in to the bloodstream in response to meals.

In type 2 diabetes, the body’s tissues, at first, are resistant to the effect of insulin.  So the pancreas has to secrete more than usual (hyperinsulinism). As the illness progresses, the pancreas cannot keep up with demand for more insulin and starts to “burn out,” producing less insulin.  This is when many type 2 diabetics need to start insulin injections.  [These are generalities; there are exceptions.]

Types of Insulin

Specific names of insulins vary by manufacturer and by country.  By convention, I capitalize only the brand names below, plus NPH and NPL.

We could break them down into two types: human (identical in structure to human insulin) and analogs (minor molecular modifications to the usual human insulin molecule).  But most people don’t care about that.  It’s more helpful to distinguish them by the timing of their action:

  • Rapid acting:  lispro (e.g., Humalog), aspart (e.g., Novolog), glulisine (e.g., Apidra)
  • Short acting:  regular (e.g., Novolin R, Humulin R)
  • Intermediate to long acting:  NPH, glargine (e.g., Lantus), detemir (e.g., Levemir), degludec (e.g., Tresiba), NPL (neutral protamine lispro)

Rapid-acting insulins have onset of action between 5 and 15 minutes, peak effect in 30 to 90 minutes, and duration of action of 2 to 4 hours.

Short-acting “regular insulin” has  onset in 30 minutes, peaks in 2 to 4 hours, and works for 5 to 8 hours.

Intermediate to long-acting insulins start working in 2 hours, don’t have a well-defined peak of action, and may keep working for 20 or more hours (glargine), for 6 to 24 hours (detemir), or 30 to 42 hours (degludec).

All these times are gross approximations.  Once the insulin is injected into the fat below the skin, it has to be absorbed into the bloodstream and transported to the tissues where it does its magic.  Lots of factors affect this process. For instance, the thicker the fat tissue at the injection site, the slower the absorption.  Absorption tends to be  faster from the abdominal wall, slower from the arms, even slower from the thighs or buttocks.  Absorption can vary from day to day in an individual even when injection site and technique are identical.

As you might have guessed, the short- and rapid-acting insulins are usually injected before a meal in anticipation of blood sugar rising as food is digested.  The intermediate- and long-acting insulins imitate the healthy body’s “basal” insulin.

Manufacturers also supply premixed insulins, combining intermdiate or long-acting insulin with a short- or rapid-acting insulin.  Examples are Humalog 75/25, Humulin 70/30, and Novolog 70/30.

Dose and Selection of Insulin

See your physician or diabetes nurse educator for details.  Many type 2 diabetics get started just with an intermediate or long-acting insulin once or twice daily, with or without diabetes drugs by mouth. Nearly all type 1’s will need a long-acting “basal” insulin (one-third to one-half of their total daily insulin requirement, plus meal-time “bolus” dosing with a rapid-acting insulin. Insulin pumps are a topic for another day.

Side Effects

By far the most common and worrisome is hypoglycemia.

Steve Parker, M.D.

Last update: August 1, 2016

Comments Off on Drug Review: Insulin

Filed under Drugs for Diabetes

Rosiglitazone On the Ropes

A week ago, MedPageToday reported that a British advisory commission recommended the diabetes drug rosiglitazone (Avandia) be withdrawn from the market.

On July 6, I wrote about evidence that rosiglitazone users seem to incur a higher risk of stroke, heart failure, and death.

If I were taking Avandia, I’d be asking my doctor about alternatives. 

Steve Parker, M.D.

2 Comments

Filed under Drugs for Diabetes

Diabetes Consumes 7% of the UK’s Drug Budget

The BBC reports that drugs for diabetes account for 7% of the United Kingdom’s National Health Service’s prescription drug budget. 

They would spend less on diabetic drugs if more diabetics adhered to low-carb eating or the Mediterranean diet.  Better yet, combine both eating styles as in the Low-Carb Mediterranean Diet.

Steve Parker, M.D.

2 Comments

Filed under Drugs for Diabetes

Diabetes Drug Rosiglitazone About to Be Pulled Off the Market?

ResearchBlogging.orgIt’s over for rosiglitazone.

Sold in the U.S. as Avandia, rosiglitazone is a drug used to control type 2 diabetes either alone or in combination with insulin, metformin, or a sulfonylurea.  It has only one competitor in its class: pioglitazone (sold as Actos).

Both drugs in the thiazolidinedione class (aka TZDs or glitazones) increase the risk of heart failure.  Prior studies had suggested that rosiglitazone increases the risk of heart attack, heart failure, and death.  Research suggested that pioglitazone actually reduces the risk of heart attack, stroke, and death.

A study just published in the Journal of the American Medical Association directly compared clinical use of rosiglitazone and pioglitazone.  Investigators looked at Medicare data involving over 227,000 patients, average age 74, average follow-up of 105 days.

Rosiglitazone comes out the loser: users had significantly higher risk of stroke, heart failure, and death.  Risk of heart attack trended a bit higher in the rosi users but did not reach statistical significance. 

The researchers also calculated the composite risk of suffering either a heart attack, stroke, heart failure, or death:  rosiglitazone risk was about 18% higher compared to pioglitazone. 

What do these numbers mean from a practical viewpoint?  The researchers calculated a “number needed to harm.” Treat 60 patients with rosi and 60 with pio for one year; the rosi group will have one extra event—heart attack, stroke, heart failure, or death—compared with the pio users.

Why put up with that risk?  There’s no good reason.  Especially when pioglitazone is available.

Implications

If you take rosiglitazone, ask your doctor to find an alternative or switch you to pioglitazone.  Soon.

Clearly, we don’t know all of the adverse effects of many of the drugs doctors prescribe, whether for diabetes or other illnesses.  We balance the good with the bad, and that equation changes over time. 

Rosiglitazone’s manufacturer may pull the drug off the market voluntarily.  If not, the FDA will do it.  Cardiovascular disease—e.g., heart attacks, strokes, heart failure—kills 68% of diabetics.  The last thing we need is a drug that increases that risk.

Within a month, you’ll see ads on U.S. television from trial lawyers asking if you or a loved one has been hurt by rosiglitazone.  “If so, call this toll-free number now…”

Steve Parker, M.D.

Reference: Graham, D., Ouellet-Hellstrom, R., MaCurdy, T., Ali, F., Sholley, C., Worrall, C., & Kelman, J. (2010). Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone JAMA: The Journal of the American Medical Association DOI: 10.1001/jama.2010.920

9 Comments

Filed under Drugs for Diabetes

Metformin Raises Risk of Vitamin B-12 Deficiency

ResearchBlogging.orgA recent study out of the Netherlands shows that type 2 diabetics taking insulin and metformin are at risk of clinically significant vitamin B12 deficiency.

B12 deficiency may cause anemia, nerve damage (neuropathy), and dementia, among other problems.

Metformin is the cornerstone of drug therapy for type 2 diabetes.  One reason is that it’s associated with improved cardiovascular disease outcomes—a claim few diabetic drugs can make.  Prior studies established that metformin interferes with B12 absorption.  The study at hand indicates that such malabsorption can reach a clinically significant degree, and that the falling blood levels are progressive over time.

No B12 here

How Was the Study Done?

Three diabetes clinic in the Netherlands provided 390 patients with type 2 diabetes between the ages of 30 and 80.  They were all treated with 1) insulin and metformin 850 mg three times daily, or 2) insulin and placebo three times daily.  B12 levels were drawn periodically over the course of the 4-year study.  Seventy-two percent of participants completed the study (the drop-outs included 30 on metformin and 16 on placebo).

What Did the Investigators Find After Four Years?

  • Compared with the placebo group, B12 levels in the metformin group dropped an average of 19%.
  • Compared to the placebo group, the metformin cohort had a 7% risk of developing B12 deficiency (blood level under 150 pmol/l) and 11% risk of dropping into the “low B12” category (level 150-220 pmol/l).

Clinical Implications

It’s unclear whether these findings apply to diabetics not taking insulin or to other ethnicities and nationalities.  I suspect they do.

The risk of developing B12 deficiency with metformin is not huge, but it seems to be real.  Once B12 deficiency does it’s damage, it may not be totally reversible.  So it’s important to know about this issue if you take or prescribe metformin.  At this point I wouldn’t depend on my doctor to be aware of this adverse drug effect, nor to remember to check B12 levels periodically.

The researchers recommend that B12 levels be checked “regularly” in patients taking metformin, without defining a time frame.  I suggest every year or two—closer to yearly if the patient has other risk factors for B12 deficiency, such as malnutrition, advanced age, removal of part of the stomach, some weight-loss surgeries, vegan diet, celiac disease, and Crohn’s disease.

Steve Parker, M.D.

de Jager, J., Kooy, A., Lehert, P., Wulffele, M., van der Kolk, J., Bets, D., Verburg, J., Donker, A., & Stehouwer, C. (2010). Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial BMJ, 340 (may19 4) DOI: 10.1136/bmj.c2181

2 Comments

Filed under Diabetes Complications, Drugs for Diabetes

Book Review: Diabetes Solution – The Complete Guide to Achieving Normal Blood Sugars

Here’s my review of Dr. Bernstein’s Diabetes Solution: The Complete Guide to Achieving Normal Blood Sugars, published in 2007.  Per Amazon.com’s rating scale, I give it five stars (I love it).  

♦   ♦   ♦ 

Dr. Richard K. Bernstein gives away thousands of dollars’ worth of medical advice in this masterpiece, Diabetes Solution.  It’s a summation of his entire medical career and a gift to the diabetes community.  

The book starts off with some incredible testimonials: reversal of diabetic nerve damage, eye damage, and erectile dysfunction.  They’re a bit off-putting to a skeptic like me, like an infomercial.  Dr. Bernstein is either lying about these or he’s not; I believe him.  His strongest testimonial is his own.  He’s been a type 1 diabetic most of his life, having acquired the disease at a time when most type 1’s never saw 55 candles on a birthday cake.  He’s in his mid-70s now and still working vigorously.  

I only found one obvious error and assume it’s a misprint. He writes that 95% of people born today in the U.S. will eventually develop diabetes.  That’s preposterous.  The U.S. Centers for Disease Control predicts that one in three born in 2000 will be diagnosed.  

Dr. Bernstein delivers lots of facts that I can neither confirm nor refute.  He’s a full-time diabetologist; I am not.  

"Put down the bread and no one will get hurt!"

  

The central problem in type 1 diabetes is that, due to a lack of insulin,  ingested carbohydrates lead to spikes (elevations) in blood sugar.  The sugar elevations themselves are toxic.  The usual insulin injections are not good imitators of a healthy pancreas gland. So Dr. Bernstein is an advocate of low-carb eating (about 30 g daily compared to the usual American 250-300 g).  He says the available insulins CAN handle the glucose produced by a high-protein meal.  

Dr. B reminds us that insulin is the main fat-building hormone, which is one reason diabetics gain weight when they start insulin, and why type 2 diabetics with insulin resistance (and high blood insulin levels) are overweight and have trouble losing weight.  You can have resistance to insulin’s blood sugar lowering action yet no resistance to its fat-building (fat-storing) action.  Insulin also stimulates hunger, so insulin-resistant diabetics are often hungry.  

“Carbohydrate counting” is a popular method for determining a dose of injected insulin.  Dr. B says the gram counts on most foods are only a rough estimate—far too rough.  He minimizes the error by minimizing the input (ingested carbs).  From his days as an engineer, he notes “small inputs, small mistakes.”  

Dr. B also cites problems with the absorption of injected insulin.  Absorption is variable: the larger the dose, the greater the variability.  So don’t eat a lot of carbs that require a large insulin dose.  For adult type 1 diabetics, his recommended rapid-acting insulins doses are usually three to five units.  If a dose larger than seven units is needed, split it into different sites.  

He recommends diabetics aim for normal glucoses (90 mg/dl or less) almost all the time, and hemoglobin A1c of 5% or less.  This is extremely tight control, tighter than any expert panel recommends.  He says this is the best way to avoid the serious complications of diabetes.   

Here’s a smattering of “facts” in the book that made an impact on me, a physician practicing internal medicine for over two decades.  I want to remember them, incorporate into my practice, or research further to confirm:  

  • Hemoglobin A1c of 5% equals an average blood sugar of 100 mg/dl (5.56 mmol/l).  For each one % higher, average glucose is 40 mg/dl (2.22  mmol/l) higher.
  • He’s against any drugs that overstimulate (“burn out”) the remaining pancreas function in type 2 diabetics: sulfonylureas, meglitinides, “phenylalanine derivatives”.  Pancreas-provoking agents cause hypoglycemia and destroy beta cell function.
  • The insulin sensitizers are metformin and thiazolidinediones.  He likes these.
  • Blood sugar normalization in type 2 diabetes and early-stage type 1 can help restore beta cell function.
  • He often speaks of preserving beta cell function.
  • He believes in “insulin-mimetic agents” like alpha lipoic acid (especially R-ALA, and take biotin with either form) and evening primrose oil.  These  are no substitute for insulin injections but allow for lower insulin doses.  ALA and evening primrose oil don’t promote fat storage like insulin does.
  • He says many cardiologists take ALA for its antioxidant properties [news to me]
  • He says rosiglitazone works within two hours [news to me] but later admits it may take 12 weeks to see maximal benefit
  • One of his goals is to preserve beta cell function if at all possible
  • He prefers rosiglitazone over pioglitazone due to fewer drug interactions
  • “Americans are fat largely because of sugar, starches, and other high-carbohydrate foods.”
  • He’s convinced that people who crave carbohydrates have inherited the problem, which also predisposes to insulin resistance and type 2 diabetes.  Low-carb diets decrease the cravings for many, in his experience.
  • In small amounts, alcohol is relatively harmless: dry wine, beer, spirits.  Very few doctors have the courage to say this.
  • If you’re in a restaurant, you can use urine sugar test strips and saliva to test for presence of sugar or flour in food
  • A rule of thumb: one gram of carbohydrate will raise blood sugar about 5 mg/dl (0.28  mmol/l) or less for most diabetic adults weighing 140 lb (64  kg) and about 2.5 mg/dl (0.139 mmol/l) in a 280-pounder (127  kg).  This must refer to type 1 diabetics or a type 2 with little residual pancreas beta cell function; variable degrees of insulin resistance and beta cell reserve in many type 2s would make this formula unreliable.
  • Be wary of maltodextrin in Splenda: it does raise blood sugar.
  • Much new to me in his section on artificial sweeteners.  Be wary of them.
  • He avoids all grains, breads, crackers, barley, oats, rice, and pasta.
  • Most diet sodas are OK.
  • Coffees with 1-2 tsp milk is OK.  Cream is OK.
  • He eats NO fruit and recommends against it.
  • He avoids beets, corn, potatoes, and beans. A slice of tomato in one cup of salad is OK.  A small amount of onion is OK.
  • String beans and snow peas are OK.
  • Cooked vegetables tend to raise blood sugar more rapidly than raw.
  • Use “Equal” aspartame tabs as a sweetener.  Don’t use “powdered” Splenda.
  • Avoid nuts: too easy to overeat.
  • For desert: sugar-free Jell-O Brand Gelatin.
  • Yogurt?  Plain, whole milk, unsweetened.  Flavor with cinnamon, Da Vinci syrups, baking flavor extracts, stevia or Equal.
  • Avoid balsamic vinegar.
  • Need fiber?  Bran crackers or soybean products.
  • “Ideally, your blood sugar should be the same after eating as it was before.”  85 mg/dl (4.72  mmol/l) is his usual goal.  If blood sugar rises by more than 10 mg/dl (0.56 mmol/l) after a meal, either the meal has to be changed or medication changed.
  • Protein is a source of glucose: keep protein amounts at meals constant from day to day, especially if taking glucose-lowering drugs.
  • The lowest-carb meal of the day should be breakafast.  Why?  Dawn phenomenon.
  • He promotes strenuous, prolonged exercise, especially weight training (extensive discussion and instruction in book).
  • Many diabetics on insulin need dose adjustments in 1/2 and 1/4 unit increments [news to me: if I ordered 4 and 1/4 units of insulin at the hospital, the nurses would laugh].
  • Typical rapid-acting insulin doses for his adult type 1 patients are 3-5 units.  The “industrial doses” of insulin seen or recommended by many physicians reflect diets too high in carbohydrate.
  • He says Lantus only acts for nine hours (nighttime injection) or 18 hours (AM injection).
  • He doesn’t like mixed insulins (e.g., 70/30).
  • Humalog and Novolog are more potent than regular insulin, so the dose is about 2/3 of the regular insulin dose
  • “Only a few of the 20 available [home glucose monitoring] machines are suitably accurate for our purposes.”  “None are suitably accurate or precise above 200 mg/dl [11.11 mmol/l].”
  • Vitamin C in doses over 250 mg interferes with fingertip glucose monitors.  Later he says doses over 500 mg cause falsely low readings.
  • He prefers regular insulin (45 minutes before meal) over Novolog and Humalog, because of its five-hour duration of action.
  • Insulin users need to check glucose levels hourly while driving.
  • His personal basal insulin is 3 units Lantus twice daily.
  • He urges use of glucose (e.g., Dextrotabs) to correct hypoglycemia.
  • He says hypoglycemia is rare on his regimen.
  • He has an entire chapter on gastroparesis.

Dr. Bernstein’s recommended eating program in a nutshell:  

  • Some similarities to the Atkins diet, which he never mentions.
  • No simple sugars or “fast-acting” carbs like bread and potatoes, because even type 2s have impaired or nonexistent phase 1 insulin response.
  • Limit carbs to an amount that will work with your injected insulin or your remaining phase 2 insulin response, if any.
  • “Stop eating when you no longer feel hungry, not when you’re stuffed.”
  • Follow a predetermined meal plan (each meal: same grams of carb and ounces of protein)
  • Six g (or less) of carbs at breakfast, 12 g (or less) at lunch and evening meal.  So his patients count carb grams and protein ounces.
  • Supplements are not required IF glucoses are controlled and eating a variety of veggies.  Otherwise you may need B-complex or multivitamin/multimineral supplement.
  • Recipes are provided.

His has four basic drug treatment plans, tailored to the individual.  They are outlined in the book.  Dr. B provides detailed notes on what he does with his personal patients.  

Overall impressions:  

  • Too complicated for most, and they won’t give up higher carb consumption.  It requires a high degree of committment and discipline.  In fact, I’ve never had a patient tell me they were on the Bernstein program.
  • If I had type 1 diabetes, I might well follow his plan or the Low-Carb Mediterranean Diet, NOT the high-carb diet recommended by the ADA and many dietitians.
  • And if I had type 2 diabetes?  Low-Carb Mediterranean Diet first, Diabetes Solution as second choice.
  • If one can get his hemoglobins A1c down to 5% with other methods, would that be just as good?  Dr. B would argue that all other methods have blood sugar swings that are too wide.
  • Many new ideas and techniques here, at least to me.
  • He pretty much reveals his entire program here, which is priceless.
  • I’m not sure this plan will work unless the patient’s treating physician is on-board.
  • His personal testimony and breadth of knowledge are very persuasive. 

Steve Parker, M.D.  

Disclosure:  I was given nothing of value by Dr. Bernstein or his publisher in return for this review.

15 Comments

Filed under Book Reviews, Carbohydrate, Drugs for Diabetes, Protein

New Page Here: Drugs for Diabetes

This is the best time in history to have diabetes.  Thanks to the advancement of science, supported by the profit motive and a degree of free market economics, we now have 10 classes of drugs to help us conquer the disease. 

I recently finished a series of brief reviews on each drug class.  Click on the Drugs for Diabetes page for links to all the reviews. 

Steve Parker, M.D.

Comments Off on New Page Here: Drugs for Diabetes

Filed under Drugs for Diabetes

Drug Review: Meglitinides (repaglinide and nateglinide)

Meglitinides—also called glinides—increase the output of insulin by the pancreas beta cells into the bloodstream.  In that respect they are similar to sulfonylurea drugs, so the two classes are sometimes lumped together as insulin secretagogues.  If the pancreas produces no insulin at all—as in most cases of type 1 diabetes—these drugs won’t work. 

Two meglitinides are available in the U.S.: repaglinide is sold as Prandin, and nateglinide is Starlix. 

Meglitinides have about the same effectiveness as sulfonylureas, but are considerably more expensive.  Repaglinide and nateglinide  increase the pancreas’ output of insulin, working faster than sulfonylureas.  They don’t last as long as sulfonylureas, which may help avoid hypoglycemia.  Glinides work mostly to reduce sugar levels after meals.   

We don’t know if these drugs affect death rates. 

Uses

May be used alone or in combination with certain other diabetic drugs.  Since they have the same mechanism of action, sulfonylureas and meglitinides would not normally be used together.  In combination therapy, you want to use drug classes that work by different mechanisms. 

Dosing

Starting dose for repaglinide is 0.5 mg by mouth before each meal.  Maximum dose is 4 mg before each meal.

Nateglinide: 120 mg by mouth immediately before each meal.

Side Effects

Hypoglycemia is the most common and potentially serious adverse effect of the meglitinides, but may be less common than with sulfonylureas.   

Weight gain is common. 

Precautions . . .

Nateglinide:  Use with great caution, if at all, in the setting of severe kidney disease and moderate to severe liver disease.

Repaglinide:  Use cautiously in severe kidney and liver disease.

Steve Parker, M.D.

Comments Off on Drug Review: Meglitinides (repaglinide and nateglinide)

Filed under Drugs for Diabetes

Vinegar and Weight Loss: Didn’t Work For Me

Mt. Fuji in Japan

Last November I started another self-experiment to see if vinegar consumption would lead to any weight loss in me.  I quit after nine weeks instead of sticking it out for the entire 12-week trial.  I just got tired of it and hadn’t seen any weight loss.  And I ran out of apple cider vinegar. 

Results?  No change in weight.

A Japanese study had shown loss of 2.2-4.4 lb in Japanese overweight study subjects.  Maybe it didn’t work for me because I wasn’t overweight.  Or because I’m not Japanese.  Or because I chose to do the experiment over the Christmas-New Years’ holiday, a notorious over-eating time of year. 

Oh, well.

Nevertheless, the vinegar option would be reasonable for an overweight person to try. 

Steve Parker, M.D. 

PS: I blogged recently about how vinegar diminishes blood sugar elevations after meals that contain complex carbohydrates.  So an overweight type 2 diabetic would be a perfect study subject.

Comments Off on Vinegar and Weight Loss: Didn’t Work For Me

Filed under Drugs for Diabetes, Overweight and Obesity

Vinegar to Treat Diabetes?

Vinegar reduces blood sugar elevations after meals containing complex carbohydrates, according to the Department of Nutrition at Arizona State University.

Meals containing carbohydrates (and to a lesser extent, proteins) raise blood sugar after meals in people with or without diabetes.  [I’ve written previously about the normal ranges of blood sugars.]  Previous studies established that a single vinegar dose around mealtime lowers postprandial (after meal) blood sugar levels by up to 50%.  Arizona investigators wanted to know the best dose and timing for reducing postprandial blood sugar elevations.

They ran multiple tests on about 40 adults who reported they were generally healthy except nine had type 2 diabetes (not taking insulin). 

Findings

Mealtime vinegar ingestion reduced postprandial (two hours after meal)  blood sugars by about 20% compared to placebo.  The test meal was white bagel (variable amounts), 20 g of butter, and 200 g of juice. 

The most effective dose of vinegar was 10 g (about two teaspoons or 10 ml) of 5% acetic acid vinegar (either Heinz apple cider vinegar or Star Fine Foods raspberry vinegar).  This equates to two tablespoons of vinaigrette dressing (two parts oil/1 part vinegar) as might be used on a salad.  The authors also say that “…two teaspoons of vinegar could be consumed palatably in hot tea with lemon at mealtime.”

Discussion

The study authors suggest that the blood-sugar-lowering effect of vinegar may be related to inhibition of digestive enzymes or to a slower rate of empyting by the stomach.  Remember that most of digestion and absorption of nutrients occurs in the small intestine; the stomach first has to empty food into the small intestine.  Vinegar seems to inhibit digestion of starch but not of simple (monosaccharide) sugars.

They also note another study that found vinegar slowed the rate of stomach emptying by almost 40% in type 1 diabetics with gastoparesis, potentially raising the risk of low blood sugar.

Take-Home Points

The development of cardiovascular disease, like heart attacks and strokes, seems to be tied especially to elevations of blood sugar after meals as compared to before-meal or fasting sugar levels.  This may be related to formation of free radicals  and inflammatory mediators.  So reduction of postprandial blood sugar elevations by vinegar may be particularly helpful in preventing heart disease.  It will be many years before we can prove this by a clinical study, if ever. 

Diabetics, especially type 2’s without gastroparesis, may better tolerate grains, fruits, and legumes—in terms of lower blood sugar spikes—if they eat them in a meal that includes two teaspoons of vinegar. 

Steve Parker, M.D.

Reference:  Johnston, Carol, et al.  Examination of the antiglycemic properties of vinegar in healthy adults.  Annals of Nutrition and Metabolism, 56 (2010): 74-79.

4 Comments

Filed under Drugs for Diabetes, Fruits, Grains, legumes